These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4151037)

  • 21. Diagnostic procedures in the evaluation of hepatic diseases. Studies to determine parasitologic etiology.
    Maekelt GA
    Lab Res Methods Biol Med; 1983; 7():129-39. PubMed ID: 6413798
    [No Abstract]   [Full Text] [Related]  

  • 22. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunity and the problem of vaccination in human protozoan infections].
    Lysenko AIa; Shuĭkina EE
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jan; (1):3-9. PubMed ID: 6340383
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunomodulation of protozoan diseases. Potential of glucan as an adjuvant.
    Cook JA; Runey GL; Holbrook TW
    Surv Immunol Res; 1983; 2(3):243-5. PubMed ID: 6675146
    [No Abstract]   [Full Text] [Related]  

  • 25. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myocardial lesions (myocarditis?) in protozoan infections].
    Mohr W
    Verh Dtsch Ges Inn Med; 1971; 77():1269-74. PubMed ID: 5005548
    [No Abstract]   [Full Text] [Related]  

  • 28. CHEMOTHERAPY OF TROPICAL DISEASES.
    TELLA A
    Curr Med Drugs; 1964 Jun; 4(10):3-8. PubMed ID: 14169083
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anemias secondary to parasitosis].
    Lorenzi TF; Jamra M
    Rev Bras Pesqui Med Biol; 1978 Jun; 11(2-3):159-80. PubMed ID: 98817
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progress in immunodiagnosis and chemotherapy of protozoan infections].
    von Sonnenburg F; Prüfer L
    Internist (Berl); 1983 Nov; 24(11):599-609. PubMed ID: 6360942
    [No Abstract]   [Full Text] [Related]  

  • 31. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization against protozoal diseases.
    Neal RA; Garnham PC; Cohen S
    Br Med Bull; 1969 May; 25(2):194-201. PubMed ID: 4918534
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of tropical diseases in the tropical tourist].
    Kyrönseppä H
    Duodecim; 1971; 87(20):1353-5. PubMed ID: 5115094
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunological phenomena in protozoan infections and their diagnostic applications, with special reference to amebiasis, malaria, leishmaniasis and toxoplasmosis].
    D'ALESSANDRO G; BURGIO GR
    Minerva Med; 1954 Dec; 45(97):1465-71. PubMed ID: 13235497
    [No Abstract]   [Full Text] [Related]  

  • 36. Recent advances in research and control of malaria, leishmaniasis, trypanosomiasis and schistosomiasis.
    Croft SL; Vivas L; Brooker S
    East Mediterr Health J; 2003 Jul; 9(4):518-33. PubMed ID: 15748049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Challenge of developing anti-parasite vaccines in the tropics].
    Rogier C
    Med Trop (Mars); 2007 Aug; 67(4):328-34. PubMed ID: 17926789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The place of serology in the diagnosis of diseases caused by protozoa].
    Wery M; Le Ray D
    Rev Med Brux; 1983 Apr; 4(4):201-7. PubMed ID: 6410480
    [No Abstract]   [Full Text] [Related]  

  • 39. Preliminary studies on the effects of orally-administered Transforming Growth Factor-beta on protozoan diseases in mice.
    Namangala B; Inoue N; Sugimoto C
    Jpn J Vet Res; 2009 Aug; 57(2):101-8. PubMed ID: 19827745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How protozoan parasites evade the immune response.
    Zambrano-Villa S; Rosales-Borjas D; Carrero JC; Ortiz-Ortiz L
    Trends Parasitol; 2002 Jun; 18(6):272-8. PubMed ID: 12036742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.